Company page

Mendus Ab

Mendus AB is a public company listed on the Swedish market under the ticker IMMU. The company has a market capitalization of approximately 33.4 million USD. Mendus focuses on developing innovative immunotherapies for cancer treatment.

profileIMMU:OMXSTOAI content: aiUpdated June 24, 2026/company/mendus-ab/c-bxesk6qu
Mendus Ab logo
Ticker
IMMU:OMXSTO
Asset type
Stock
Market cap
$33.4M
Sector
Health Technology
Industry
Biotechnology
Exchange
OMXSTO
Currency
SEK